Elucid Bioimaging, Inc. is a medical imaging company that is building the Computer-Aided Phenotyping (CAP) Platform, a cutting-edge bioimaging system that can reduce the rates of misclassification that lead to increased medical costs and over- and under-diagnosis in cardiology and oncology.

Industry Categories

Industry Biomedical
Sub-industry
Focus Areas
Focus Areas - detailed

University

University
Principal Investigator Andrew Buckler

Company

Web http://elucidbio.com
Address Wenham, MA
Incubator / Accelerator / Lab Facility
Phone
Email

Timeline

  • 2013 – Founded


No files attached to this page.

Add a New Comment